Home

FOR ADVANCED THERAPEUTICS

HIGH PERFORMANCE CELL TECHNOLOGIES

VIRAL VECTORS AND VACCINES

CELL LINES FOR

STABLE AAV PRODUCER CELL LINES

ELEVECTA®

09/27/2022 - 09/30/2022

BOSTON, MA, USA

CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises various platform technologies for gene therapy vectors, vector vaccines and complex recombinant proteins.

In the viral vector space, ELEVECTA® is the technology of choice for AAV manufacturing. For RCA-free Adenoviral vectors,  the CAP® Ad Technology is the perfect fit. CAP® Go is the solution to enable the production of complex and highly glycosylated recombinant proteins.

STABLE AAV PRODUCER CELL LINES

RCA-FREE ADENOVIRAL VECTORS

GLYCO-OPTIMIZED PROTEINS

CEVEC’S LICENSE PARTNER RZNOMICS INC. RECEIVES APPROVAL TO INITIATE CLINICAL DEVELOPMENT OF CAP® AD TECHNOLOGY-PRODUCED GENE THERAPY VECTOR IN LIVER CANCER PATIENTS

Cologne, Germany, July 13, 2022

CELL & GENE THERAPY MANUFACTURING & COMMERCIALIZATION CONFERENCE
BOSTON, MA, USA

09/27/2022 – 09/30/2022

OPEN POSITIONS (M/W/D)

  • RESEARCH ASSISTANT IN MOLECULAR BIOANALYTICS

  • TECHNISCHE/R ASSISTENT/IN ZELLLINIENENTWICKLUNG

KEEP IN TOUCH

Subscribe to receive CEVEC’s latest Press Releases, Conference Information and Webinar Invitations according to our Privacy Policy.

© CEVEC Pharmaceuticals GmbH 2022